Podcast
Hear the podcastG. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech posts gain in February as broader markets strengthen March 03, 2010 | Press Release
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
See all News
All News
Burrill & Company and WR Hambrecht + Co to collaborate on OpenIPO® transactions
Joint venture will focus on select healthcare companies
October 09, 2009
FDA Commissioner Dr. Margaret Hamburg headlines at the Burrill Annual Personalized Medicine Meeting
September 16, 2009
NewBridge Pharmaceuticals Announces Licensing of Pylera® for Middle East, Africa, Turkey & Caspian Region
July 22, 2009
Burrill Merchant Banking Advises Adlyfe on Alzheimer’s Biomarker Partnership with Wyeth
March 17, 2009
Biotech Industry Turns a Profit for the First Time, But Milestone Overshadowed as Companies Struggle for Survival, Report Finds
February 25, 2009
Burrill Merchant Banking advises Mitsubishi Tanabe Pharma Corporation on transactions with Cytochroma Inc.
September 08, 2008
Biotech red hot in July as potential blockbuster M&A deals awake investors from their summer slumber
August 01, 2008
Burrill Merchant Banking Advises QLT USA on divestment of QLT USA, INC.'s Generic Dermatology and Manufacturing Business
April 12, 2007
Hal Gerber, M.D Joins Burrill & Company’s Merchant Banking Group To Further Expand M&A Services
August 01, 2005
Biotech Recognized as One of San Francisco Mayor Gavin Newsom's First Year Accomplishments
January 07, 2005
Burrill & Company's Merchant Banking Practice Announces Increasing Spin-Out Activity From Pharmaceutical Companies
January 07, 2005
Burrill & Company Announces Promotions and Organizational Changes to Reflect the Growth of its Business
January 05, 2005
G. Steven Burrill is Recognized as Biotech Investment Visionary by Scientific American
November 20, 2002



